- US-listed companies
- Moderna, Inc.
- Cash flow
Moderna, Inc.MRNA
Market cap
$12.7B
P/E ratio
| 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Depreciation & amortization | 25 | 31 | 31 | 232 | 348 | - | - |
| Stock-based compensation | 73 | 81 | 93 | 142 | 226 | 305 | 429 |
| Cash from operations | -331 | -459 | 2,027 | 13,620 | 4,981 | -3,118 | -3,004 |
| Capital expenditures | -106 | -32 | -67 | -284 | -400 | -707 | -1,051 |
| Cash from investing | -372 | -15 | -1,672 | -8,523 | -5,176 | 4,206 | 1,949 |
| Repurchases of common stock | - | - | - | 857 | 3,329 | 1,153 | - |
| Cash from financing | 1,227 | 51 | 2,033 | -873 | -3,448 | -1,377 | 56 |
| Free cash flow | |||||||
| FCF margin (%) |